Company Overview and News

Broker's call: Shriram Transport Fin (Buy)

2018-04-11 thehindubusinessline
Over the past few years, while commercial vehicle volumes have been stagnant, there has been a marked shift in mix towards higher-tonnage vehicles. In addition, price hikes in the past two years have been healthy (18-20 per cent on new vehicles).
Upvote Downvote

Closing Bell: Sensex rises 108 pts, Nifty ends above 10,150; banks, financials lead

2018-03-27 moneycontrol
3:30 pm Market Closing: Benchmark indices continued to trade higher for second consecutive session, with the Sensex rising 107.98 points to 33,174.39, tracking positive move in global equities.
Upvote Downvote

Market Live: Sensex up over 150 pts, Europe strong; PSU banks outperform, SBI up 3%

2018-03-27 moneycontrol
2:10 pm Government Investment in IOB: Indian Overseas Bank informed exchanges that it has received an amount of Rs 388.94 crore on March 26, 2018 towards contribution of the Central Government in the preferential allotment of equity shares of the bank during the FY18, as Government's investment.
Upvote Downvote

Market Live: Sensex, Nifty mildly higher; Eicher Motors, HPCL, BPCL, Bajaj Fin up 2-3%

2018-03-27 moneycontrol
12:40 pm Europe Trade: European equities opened higher as concerns over a global trade war eased.
Upvote Downvote

Market Live: Sensex, all sectoral indices off day#39;s high; HDFC twins decline

2018-03-27 moneycontrol
received orders worth Rs 747 crore from Nuclear Power Corporation of India Ltd (NPCIL) to supply steam generators and end shields for its indigenously designed 700MWe Pressurized Heavy Water Reactors (PHWR) to be set up at Gorakhpur Haryana Anu Vidyut Pariyojana (GHAVP) in Fatehabad district of Haryana.
Upvote Downvote

Expect return of 18-20% AUM growth; upbeat on demand: Shriram Transport Fin

2018-03-16 moneycontrol
Umesh Revankar, MD, Shriram Transport Finance in an interview to CNBC-TV18 said the asset under management (AUM) growth has been around 18 percent and is expected to be around 18-20 percent for the next few quarters.
Upvote Downvote

Top buzzing midcap stocks to trade on March 15

2018-03-15 moneycontrol
Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have - Wipro, Puravankara, Shriram Transport Finance, HDIL, Zuari Agro Chemicals, Madras Fertilizers, NR Agarwal Industries and MMTC.
Upvote Downvote

Shriram Transport Fin: Gets ₹156 cr from arm

2018-02-07 thehindubusinessline
Shriram Transport Finance Company (STFC) has transferred 1.663 crore equity shares of Shriram Automall India (SAMIL) to MXC Solutions India Private Ltd (MXC) at ₹94.03 a share, aggregating to ₹156.37 crore. As a result, MXC has become majority shareholder in SAMIL, and SAMIL has ceased to be a subsidiary of Shriram Transport Finance Company. Shares of the company will remain in focus, as investors will closely monitor the development.
Upvote Downvote

Mahindra Finance in talks to raise $300 million via masala bonds

2018-02-05 livemint
Mumbai: Mahindra and Mahindra Financial Services Ltd (Mahindra Finance) is in talks to raise as much as $300 million via masala bonds, according to two people directly aware of the company’s discussions with potential lenders.
Upvote Downvote

PE-backed CarTrade to acquire Shriram Automall for Rs 1.56 billion

2018-01-24 business-standard
CarTrade, a private equity-backed firm, is set to acquire a majority stake in Shriram Automall (SAMIL), which sells used trucks, buses and other vehicles, from Shriram Transport Finance Corporation (STFC) for Rs 1.56 billion. An agreement was signed on this between STFC, Shriram Automall India, and MXC Solutions, which operates and After the acquisition MXC Solutions will be the majority shareholder.
Upvote Downvote

Fiscal slippages likely to spook market

2018-01-23 thehindubusinessline
Union Budget 2018-19 would be the toughest one for the BJP government so far in its current tenure. This is because it would be a tight-rope walk for the government in terms of garnering higher revenue collections amid challenges faced by mid and small corporates post GST. The short-term slowdown caused by GST and demonetisation are other factors. Meanwhile, rising crude and commodity prices beyond a particular level have already worsened the macroeconomic scenario in recent times.
Upvote Downvote

Experts call for private sector participation to develop infrastructure

2018-01-19 thehindubusinessline
Terming India’s fiscal situation as serious, corporates and experts have called for prudence to cut deficit without reducing spending on the infrastructure sector. At a time when 40 per cent of the government’s revenues were going towards interest payments, it was important to increase private sector participation in infrastructure to keep costs under check.
Upvote Downvote

IDFC Bank to grow retail business with Capital First deal

2018-01-15 livemint
Mumbai: IDFC Bank Ltd may have finally found a way to shed its infrastructure finance company image and become a people’s bank—by merging Capital First Ltd with itself. The merger could be a way for the lender to build its retail book, something it has been unable to do in the two-and-a-half years since becoming a bank.
Upvote Downvote

Broker's call: Shriram Transport (Buy)

2018-01-09 thehindubusinessline
Shriram Transport Finance (STFC) is the pioneer and largest player in the used CV financing space and is a part of the ‘Shriram’ conglomerate that has a significant presence in varied financial services. STFC was incorporated in 1979 and started financing the much-neglected small truck-owners. Currently, it has an AUM of ₹85,463 crore, growing 13.2 per cent y-o-y (about 87 per cent is derived from used vehicles) as on Q2FY18.
Upvote Downvote

Bond losses to hurt Q3 earnings of banks; NBFCs may sail through

2018-01-09 moneycontrol
The December quarter earnings season may hold little cheer for banks, as the steep drop in bond prices is expected to add to the existing bad loan problem.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...